 The Star-Ledger – NJ.com |
US FDA Approves New J&J HIV Drug
Wall Street Journal WASHINGTON (Dow Jones)–The US Food and Drug Administration Friday approved a new HIV drug made by a unit of Johnson & Johnson. (JNJ). The drug, Edurant, also known by its generic name rilpivirine, was approved for use in … US FDA approves J&J HIV drug for combination use FDA Okays New HIV Drug FDA Approves a New Drug To Treat HIV |
- Life-extending prostate cancer pill could be available in a year – Daily Mail
- Test Approved to Monitor Levels of Kidney Rejection Drug – BusinessWeek
- FDA Approves Roche Drug To Treat Type Of Juvenile Arthritis – Wall Street Journal
- Endo Says FDA Approves Fortesta Gel To Treat Low Testosterone – Wall Street Journal
- FDA warns high dose of simvastatin can cause muscle damage – Xinhua
- Viibryd Approved for Major Depressive Disorder – BusinessWeek
- FDA Approves Drug to Treat Hospital Scourge – New York Times
- FDA Okays First Treatment for Rare Thyroid Cancer – MedPage Today
- FDA Approves Band Device for Less Obese – New York Times
- FDA Approves Band Device for Less Obese – New York Times
Stay updated! Follow us on twitter and subscribe to our feed via Feedburner.
No Comments